Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alo- pecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995;70(7):628-33.

Shellow WV, Edwards JE, Koo JY. Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol 1992;31(3):186-9.

Kyriakis KP, Paltatzidou K, Kosma E, Sofouri E, Tadros A, Rachioti E. Alopecia areata prevalence by gender and age. J Eur Acad Dermatol Venereol 2009;23(5):572-3. Epub 2008 Sep 8.

Anderson I. Alopecia areata: a clinical study. Br Med J 1950;2(4691):1250-2.

Lew BL, Shin MK, Sim WY. Acute diffuse and total alopecia: a new sub- type of alopecia areata with a favorable prognosis. J Am Acad Dermatol 2009;60(1):85-93. Epub 2008 Nov 6.

Finner AM. Alopecia areata: clinical presentation, diagnosis, and unusual cases. Dermatol Ther 2011;24(3):348-54.

Kasumagic-Halilovic E, Prohic A. Nail changes in alopecia areata: frequency and clinical presentation. J Eur Acad Dermatol Venereol 2009;23(2):240-1. Epub 2008 Jun 1.

Price VH, Colombe BW (1996) Heritable factors distinguish two types of alopecia areata. Dermatol Clin 14(4):679–689

Paus R, Ito N, Takigawa M, Ito T (2003) The hair follicle and immune privilege. J Investig Dermatol Symp Proc 8(2):188–194.

Paus R, Bertolini M (2013) The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives. Investig Dermatol Symp Proc 16(1):S25–S27.

Friedmann PS (1981) Alopecia areata and auto-immunity. Br J Dermatol 105(2):153–157

Tobin DJ, Orentreich N, Fenton DA, Bystryn JC (1994) Antibodies to hair follicles in alopecia areata. J Invest Dermatol 102(5):721–724.

Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S (1994) Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 33(9):632–633.

Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006;20(9):1055-60.

Chu TW, AlJasser M, Alharbi A, Abahussein O, McElwee K, Shapiro J (2015) Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: an intrasubject pilot study. J Am Acad Dermatol 73(2):338–340

Kar BR, Handa S, Dogra S, Kumar B (2005) Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 52(2):287–290

Agarwal A, Nath J, Barua KN (2006) Twice weekly 5 mg betamethasone oral pulse therapy in the treatment of alopecia areata. J Eur Acad Dermatol Venereol 20(10):1375–1376

Tosti A, Iorizzo M, Botta GL, Milani M (2006) Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol 20:1243–1247

Tiwary AK, Mishra DK, Chaudhary SS (2016) Comparative study of efficacy and safety of topical squaric acid dibutylester and diphenylcyclopropenone for the treatment of alopecia areata. N Am J Med Sci 8(6):237–242

Chartaux E, Joly P (2010) Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral cor- ticosteroids in the treatment of alopecia areata totalis or universalis. Ann Dermatol Venereol 137(8–9):507–513

Lattouf C, Jimenez JJ, Tosti A et al (2015) Treatment of alopecia areata with simvastatin/ezetimibe. J Am Acad Dermatol 72(2): 359–361

Olsen EA, Carson SC, Turney EA (1992) Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 128(11):1467–1467

Yeo IK, Ko EJ, No YA et al (2015) Comparison of high-dose corticosteroid pulse therapy and combination therapy using oral cyclosporine with low-dose corticosteroid in severe alopecia Areata. Ann Dermatol 27(6):676–681

Taylor CR, Hawk JL (1995) PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years’ experience at St John’s Institute of Dermatology. Br J Dermatol 133(6):914–918

Trink A, Sorbellini E, Bezzola P, Rodella L, Rezzani R, Ramot Y, Rinaldi F (2013) A randomized, double-blind, placebo- and ac- tive-controlled, half-head study to evaluate the effects of platelet- rich plasma on alopecia areata. Br J Dermatol 169(3):690–694

Waldmann TA (2013) The biology of IL-15: implications for can- cer therapy and the treatment of autoimmune disorders. J Invest Dermatol Symp Proc 16:S28–S30

Falto-Aizpurua L, Choudhary S, Tosti A (2014) Emerging treat- ments in alopecia. Expert Opin Emerg Drugs 19(4):545–556

Divito SJ, Kupper TS (2014) Inhibiting Janus kinases to treat alopecia areata. Nat Med 20(9):989–990